Randal W. Scott, Director at BridgeBio Pharma, Inc. (BBIO), bought 16,000 shares at $62.50 ($1.0M) on 2021-02-17, disclosed to the SEC on 2021-02-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| BBIO | SELL | 2025-11-19 | $1.3M | — | Filing → |
| BBIO | SELL | 2024-06-05 | $76K | — | Filing → |
| BBIO | SELL | 2024-03-05 | $85K | — | Filing → |